GSD Goldshield Grp

RNS Number:6064X
Goldshield Group PLC
21 June 2002


Immediate Release                                                  21 June 2002



                      Goldshield Group plc (the "Company")



  Proposal for the Company to be authorised to purchase its own equity shares



The Board announces that at the Company's Annual General Meeting ("AGM") to take
place on 22 July 2002, a resolution to give the Company a general authority to
acquire its own equity shares will be proposed.



The Company is seeking authority to acquire in the open market up to 10% of the
issued share capital of the Company. The maximum price the Company will be
permitted to pay will be equal to 5% above the average middle market quotations
for the five business days preceding the transaction and the minimum price will
be 5 pence per share (being the nominal value of the shares).



                                    - ENDS -



For further information:
Goldshield Group plc
Rakesh Patel, Finance Director                          +44 (0) 20 8649 8500

Buchanan Communications                                 +44 (0) 20 7466 5000
Nicola How / Louise Bolton



Notes to editors:

Goldshield Group PLC is a growing and profitable, marketing-led, British
pharmaceutical company based in Croydon, Surrey, it was founded in 1990, to sell
healthcare and pharmaceutical products internationally. In June 1998 Group
floated on the London Stock Exchange and currently has a market capitalisation
of around £145 million.



                      This information is provided by RNS
            The company news service from the London Stock Exchange

Goldshield (LSE:GSD)
Historical Stock Chart
From Jun 2024 to Jul 2024

Goldshield (LSE:GSD)
Historical Stock Chart
From Jul 2023 to Jul 2024